Merck Sued For Securities Fraud Over Cholesterol Drug Trial
Law360, Los Angeles (December 4, 2013, 4:38 PM EST) -- North Sound Capital LLC and two other institutional funds have sued Merck & Co. Inc. and its subsidiary for allegedly misrepresenting a crucial clinical study for its anti-cholesterol agents Zetia and Vytorin, according to court documents made public in New Jersey federal court on Wednesday.
North Sound, United Food Commercial Workers Local 1500 Pension Fund and Colonial First State Investments Ltd. accuse the defendants of common law fraud and of violating of the Securities Exchange Act of 1934 for concealing material and making false statements that artificially inflated the value of Schering-Plough Corp. securities from Jan. 3, 2007, to March 28,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!